IL49695A - Synergistic analgetic compositions containing an indole acetic acid derivative and a narcotic or antinarcotic analgesic compound - Google Patents

Synergistic analgetic compositions containing an indole acetic acid derivative and a narcotic or antinarcotic analgesic compound

Info

Publication number
IL49695A
IL49695A IL49695A IL4969576A IL49695A IL 49695 A IL49695 A IL 49695A IL 49695 A IL49695 A IL 49695A IL 4969576 A IL4969576 A IL 4969576A IL 49695 A IL49695 A IL 49695A
Authority
IL
Israel
Prior art keywords
antinarcotic
narcotic
synergistic
acetic acid
compositions containing
Prior art date
Application number
IL49695A
Other languages
English (en)
Other versions
IL49695A0 (en
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of IL49695A0 publication Critical patent/IL49695A0/xx
Publication of IL49695A publication Critical patent/IL49695A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL49695A 1975-06-02 1976-06-01 Synergistic analgetic compositions containing an indole acetic acid derivative and a narcotic or antinarcotic analgesic compound IL49695A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/582,757 US4029798A (en) 1975-06-02 1975-06-02 Analgetic composition

Publications (2)

Publication Number Publication Date
IL49695A0 IL49695A0 (en) 1976-09-30
IL49695A true IL49695A (en) 1978-12-17

Family

ID=24330416

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49695A IL49695A (en) 1975-06-02 1976-06-01 Synergistic analgetic compositions containing an indole acetic acid derivative and a narcotic or antinarcotic analgesic compound

Country Status (9)

Country Link
US (2) US4029798A (fr)
JP (1) JPS51142544A (fr)
BE (1) BE842440A (fr)
CA (1) CA1062616A (fr)
FR (1) FR2313045A1 (fr)
GB (1) GB1513646A (fr)
IL (1) IL49695A (fr)
NL (1) NL7605322A (fr)
ZA (1) ZA763211B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
SU975016A1 (ru) * 1979-12-17 1982-11-23 Московский научно-исследовательский онкологический институт им.П.А.Герцена Болеутол ющее средство
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
CN1653050B (zh) 2002-05-17 2013-04-24 詹肯生物科学公司 阿片和阿片样化合物及其用途
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
US3250678A (en) * 1963-01-16 1966-05-10 Sterling Drug Inc Analgesia producing benzazocines
US3576800A (en) * 1966-01-12 1971-04-27 Sumitomo Chemical Co 1-acyl-3-indolyl aliphatic acid derivatives and their method of preparation
US3551446A (en) * 1967-06-08 1970-12-29 Sumitomo Chemical Co 1-aryloxyalkylcarbonyl-3-indolyl aliphatic acid derivatives
US3833595A (en) * 1968-12-26 1974-09-03 Sumitomo Chemical Co 2-aroylalkyl benzomorphans
HU163443B (fr) * 1970-08-26 1973-08-28
HU166378B (fr) * 1972-12-19 1975-03-28
US4027024A (en) * 1972-12-19 1977-05-31 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Pharmaceutical composition having synergistic analgesic activity

Also Published As

Publication number Publication date
GB1513646A (en) 1978-06-07
US4083981A (en) 1978-04-11
JPS5330787B2 (fr) 1978-08-29
US4029798A (en) 1977-06-14
FR2313045A1 (fr) 1976-12-31
NL7605322A (nl) 1976-12-06
FR2313045B1 (fr) 1978-11-17
ZA763211B (en) 1977-05-25
JPS51142544A (en) 1976-12-08
CA1062616A (fr) 1979-09-18
AU1442776A (en) 1977-07-14
IL49695A0 (en) 1976-09-30
BE842440A (fr) 1976-10-01

Similar Documents

Publication Publication Date Title
IL50881A0 (en) Pharmaceutical compositions containing certain indole derivatives
GB1516780A (en) Piperidine derivatives
NZ181726A (en) Pyrrolidine derivatives and pharmaceutical compositions
IL49695A (en) Synergistic analgetic compositions containing an indole acetic acid derivative and a narcotic or antinarcotic analgesic compound
NZ182665A (en) Amine derivatives and pharmaceutical compositions
NZ182190A (en) Clavulanic acid derivatives and pharmaceutical compositions
JPS5463086A (en) 33*22hydroxyy44*substituted*phenyl* azacycloalkane as analgesic*its derivative and intermediate
JPS5217475A (en) New 11*benzoazolii*alkyl* piperidine derivatives
IL49280A (en) Pharmaceutical compositions containing substituted o-hydroxy-benzophenone derivatives
AU507272B2 (en) Pharmaceutical compositions and compounds
NZ191169A (en) N-substituted aziridine-2-carboxylic acid derivatives and pharmaceutical compositions
JPS5262281A (en) Racemic compounds and their intermediates useful as analgesic agents
JPS55153764A (en) Indoline compound
GB1541933A (en) Pharmaceutical compositions containing a diastereoisomer of a phenylalkylaminoethanol derivative
IL50296A (en) Synergistic herbicidal compositions containing 3-methyl-4-amino-6-phenyl-1,2,4-triazin-5-one and 4-phenoxy-phenoxy-alkane carboxylic acid derivatives
GB1555679A (en) Dichlorophenoxy acetic acid derrivative and pharmaceutical compositions containing it
JPS5279032A (en) Crude drug compound
GB1555038A (en) Process for the preparation of 4-p-fluorobenzoyl)-1-(3-p-fluorobenzoyl propyl)piperidine and salts thereof
IL50584A0 (en) Herbicidal synergistic compositions containing certain triazine derivatives and certain carboxylic acids
AU498958B2 (en) Phthalimidine & benzisothiazoline derivatives
JPS51141837A (en) Prodution of para isobutylphenyl acetic acid derivatives
IL60901A (en) Synergistic analgesic pharmaceutical compositions containing nalbuphine and acetylsalicyclic acid derivatives
DE3263555D1 (en) Analgesic compositions containing an opiate alkaloid compound and a carbazole compound
JPS527969A (en) Piperidine carboxylic acid derivatives and preparation method thereof and stabilized komposite to ultrviolet ray deterioration by containing the compound
IL47225A0 (en) Synergistic pharmaceutical compositions comprising an ergot clavine alkaloid and a phosphodiesterase inhibitor